Brainomix 360 Stroke imaging was utilized to improve and standardize the grading of baseline stroke severity, prior to treatment in patients enrolled in Argenica Therapeutic's Phase II study of neuroprotective ARG-007 Brainomix AI core lab uses regulatory cleared stroke technology,...
Hence then, the article about brainomix ai technology reveals efficacy of novel neuroprotective drug candidate in severe acute ischemic stroke patients was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Brainomix AI Technology Reveals Efficacy of Novel Neuroprotective Drug Candidate in Severe Acute Ischemic Stroke Patients )
Also on site :
- MDA SPACE ANNOUNCES CLOSING OF C$250 MILLION OFFERING OF SENIOR UNSECURED NOTES DUE 2030
- CCSC Technology International Holdings Limited Reports Financial Results for the Six Months Ended September 30, 2025
- Supply and Tariff Woes Send Copper Prices to Record High above $12,000